In keeping with this hypothesis, olvanil, a non-pungent vanilloid agonist that activates TRPV1 more slowly than capsaicin does [81,82], was shown to suppress metastasis of breast carcinoma without altering the rate of primary tumor growth [83]. This evidence concerns the gene TRPV1 and breast carcinoma.